Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0A4D stock hub

LON/0A4D has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0A4Dis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

97.9M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0A4D

In the news

Latest news · LON/0A4D

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-94

P25 n/aP50 n/aP75 n/a

ROIC-60.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0A4D market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

145

Groups with data

Currency

USD

Showing 145 of 145 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	35
Employees Change	-9%
Employees Change Percent	-20.45
Enterprise value	$76.2M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Isin	US29446K1060
Last refreshed	2026-05-10
Market cap	$97.9M
Price	$2.16
Price currency	USD
Sic	2836
Symbol	lon/0A4D
Website	https://www.equilliumbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-17%
EV Earnings	-4.58x
EV/FCF	-4.5x
FCF yield	-17.3%
P/B ratio	4.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-16.6M
Profit Per Employee	$-475,478
ROA	-51.39
Roa5y	-27.29
ROCE	-81.63
ROE	-93.99
Roe5y	-73.15
ROIC	-60.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	414.74%
Cagr3y	56.44%
Cagr5y	-19.28%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$23.7M
Cash	$22.5M
Current Assets	$22.8M
Current Liabilities	$2.2M
Debt	$534,217
Debt Equity	$0.03
Debt FCF	$-0.03
Equity	$21.2M
Liabilities	$2.4M
Long Term Assets	$925,233
Long Term Liabilities	$292,340
Net Cash	$22M
Net Cash By Market Cap	$22.43
Net Cash Growth	33.2%
Net Debt Equity	$-1.03
Tangible Book Value	$21.2M
Tangible Book Value Per Share	$0.35
WACC	13.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.58
Net Working Capital	$-1.3M
Quick ratio	10.36
Working Capital	$20.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-62.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	414.16%
200-day SMA	1.42
3Y total return	282.97%
50-day SMA	2.01
50-day SMA vs 200-day SMA	50over200
5Y total return	-65.73%
All Time High	11.01
All Time High Change	-80.37%
All Time High Date	2021-02-12
All Time Low	0.28
All Time Low Change	671.43%
All Time Low Date	2025-06-24
ATR	0.16
Beta	1.74
Ch YTD	41.64
High	2.25
High52	2.61
High52 Date	2026-03-16
High52ch	-17.24%
Low	2.15
Low52	0.28
Low52 Date	2025-06-24
Low52ch	671.43%
Ma50ch	7.25%
Price vs 200-day SMA	52.54%
RSI	54.58
RSI Monthly	59.49
RSI Weekly	60.69
Sharpe ratio	1.37x
Sortino ratio	2.78
Total Return	-62.07%
Tr YTD	41.64
Tr1m	9.65%
Tr1w	4.35%
Tr3m	41.18%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-17.6M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31,498,337%
Shares Insiders	10.85%
Shares Institutions	34.16%
Shares Qo Q	40.66%
Shares Yo Y	62.07%
Short Ratio	6.27

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-18.7M
Average Volume	8,916.6x
Bv Per Share	0.35
CAPEX	$-35,664
Ch1m	9.65
Ch1w	4.35
Ch1y	414.2
Ch3m	41.18
Ch3y	283
Ch5y	-65.73
Ch6m	100
Change	-1.37%
Change From Open	0.47
Close	2.19
Days Gap	-1.83
Depreciation Amortization	85,087.6
Dollar Volume	10,543
Earnings Date	2026-05-12
EBIT	$-17.6M
EBITDA	$-17.5M
EPS	$-0.29
F Score	1
FCF	$-16.9M
FCF EV Yield	-22.22x
Financing CF	22,607,261
Fiscal Year End	December
Founded	2,017
Investing CF	3,316,752
Is Primary Listing	0
Last Earnings Date	2025-11-11
Last Report Date	2025-12-31
Ma150	1.56
Ma150ch	38.73%
Ma20	2.07
Ma20ch	4.3%
Net CF	9,058,656
Next Earnings Date	2026-05-12
Open	2.15
Position In Range	10
Ppne	602,948.5
Price Date	2026-05-08
Ptbv Ratio	4.61
Relative Volume	0.55x
Share Based Comp	1,725,246
Tr6m	100.02%
Volume	4,881

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0A4D pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0A4D stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0A4D?

Insider, institutional, and short-interest positioning.

Institutional ownership

+34.2%

Share of float held by funds and institutions

Insider ownership

+10.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0A4D momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.6

Neutral momentum band

Price vs 200-day MA

+52.5%

50/200-day relationship not available

Beta (5Y)

1.74

More volatile than the market

Sharpe ratio

1.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0A4D

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0A4D stock rating?

lon/0A4D is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0A4D analysis?

The full report lives at /stocks/lon/0A4D/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0A4D?

The latest report frames lon/0A4D around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0A4D page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.